期刊文献+
共找到479篇文章
< 1 2 24 >
每页显示 20 50 100
LXR及其靶基因COX-2和CETP在肥胖OSAHS幼鼠肝组织中的保护作用
1
作者 赖明昱 叶新华 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2024年第6期895-901,共7页
目的阐明肝X受体(liver X receptor,LXR)及其靶基因环氧化酶-2(cyclooxygenase-2,COX-2)、胆固醇酯转移蛋白(cholesteryl ester transfer protein,CETP)的高表达是肥胖幼鼠阻塞性睡眠呼吸暂停综合征(obstructive sleep apnea-hypopnea s... 目的阐明肝X受体(liver X receptor,LXR)及其靶基因环氧化酶-2(cyclooxygenase-2,COX-2)、胆固醇酯转移蛋白(cholesteryl ester transfer protein,CETP)的高表达是肥胖幼鼠阻塞性睡眠呼吸暂停综合征(obstructive sleep apnea-hypopnea syndrome,OSAHS)发病过程中的保护性因素,为肥胖儿童OSAHS的发病机制提供基础研究资料。方法24只3~4周龄雄性Wistar幼鼠分为正常对照组(control组)、单纯肥胖组(obesity组)、单纯OSAHS组(OSAHS组)、肥胖+OSAHS组(obesity+OSAHS组)。HE染色观察幼鼠肝组织病理变化;蛋白免疫印迹法(Western blotting)检测幼鼠肝组织中LXRα、COX-2、CETP的表达水平;运用免疫组化方法检测幼鼠肝组织中LXRα、COX-2、CETP的表达水平及分布情况。结果单纯肥胖组和肥胖+OSAHS组幼鼠体质量、总胆固醇(total cholesterol,TC)、甘油三酯(triglyceride,TG)含量与正常对照组相比均明显增加(P<0.05),单纯OSAHS组和肥胖+OSAHS组幼鼠血氧饱和度与正常对照组相比均明显降低(P<0.05)。单纯肥胖组、单纯OSAHS组及肥胖+OSAHS组肝组织与正常对照组肝组织相比均有明显损伤,肥胖+OSAHS组肝组织损伤较单纯肥胖组、单纯OSAHS组肝组织损伤程度明显升高。单纯OSAHS组和单纯肥胖组幼鼠肝组织中LXRα、COX-2、CETP表达水平较正常对照组均明显升高(P<0.05)。肥胖+OSAHS组幼鼠肝组织中LXRα、COX-2、CETP表达水平较其余各组均明显升高(P<0.05)。结论LXR及其靶基因COX-2、CETP在肥胖OSAHS幼鼠肝脏中高表达,是发病过程中的可能保护性因素。 展开更多
关键词 x受体(lxr) 阻塞性睡眠呼吸暂停综合征(OSAHS) 肥胖 幼鼠 保护作用
下载PDF
Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease 被引量:7
2
作者 Jiao-Ya Xu Zhong-Ping Li +1 位作者 Li Zhang Guang Ji 《World Journal of Gastroenterology》 SCIE CAS 2014年第37期13493-13500,共8页
Non-alcoholic fatty liver disease(NAFLD) is the hepatic manifestation of metabolic syndrome and is one of the most prevalent liver disorders worldwide. NAFLD can gradually progress to liver inflammation, fibrosis, cir... Non-alcoholic fatty liver disease(NAFLD) is the hepatic manifestation of metabolic syndrome and is one of the most prevalent liver disorders worldwide. NAFLD can gradually progress to liver inflammation, fibrosis, cirrhosis and even hepatocellular carcinoma. However, the pathogenesis of NAFLD is complex, and no efficient pharmaceutic treatments have yet been established for NAFLD. Accumulating data have shown that the farnesoid X receptor(FXR) plays important roles not only in bile acid metabolism, but also in lipid and carbohydrate homeostasis, inflammatory responses, among others. In this review, we aim to highlight the role of FXR in the pathogenesis and treatment of NAFLD. 展开更多
关键词 Farnesoid x receptor Non-alcoholic fatty liver disease MECHANISM THERAPY Lipid metabolism
下载PDF
Pravastatin activates the expression of farnesoid X receptor and liver X receptor alpha in Hep3B cells 被引量:3
3
作者 Hyun Woo Byun Eun Mi Hong +5 位作者 Soo Hee Park Dong Hee Koh Min Ho Choi Hyun Joo Jang Sea Hyub Kae Jin Lee 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2014年第1期65-73,共9页
BACKGROUND: Statins are suggested to preserve gallbladder function by suppressing pro-inflammatory cytokines and preventing cholesterol accumulation in gallbladder epithelial cells. They also affect cross-talk among t... BACKGROUND: Statins are suggested to preserve gallbladder function by suppressing pro-inflammatory cytokines and preventing cholesterol accumulation in gallbladder epithelial cells. They also affect cross-talk among the nuclear hormone receptors that regulate cholesterol-bile acid metabolism in the nuclei of hepatocytes. However, there is controversy over whether or how statins change the expression of peroxisome proliferator-activated receptor(PPAR)α, PPARγ, liver X receptor α(LXRα), farnesoid X receptor(FXR), ABCG5, ABCG8, and 7α-hydroxylase(CYP7A1) which are directly involved in the cholesterol saturation index in bile. METHODS: Human Hep3B cells were cultured on dishes. MTT assays were performed to determine the appropriate concentrations of reagents to be used. The protein expression of PPARα and PPARγ was measured by Western blotting analysis, and the mRNA expression of LXRα, FXR, ABCG5, ABCG8 and CYP7A1 was estimated by RT-PCR. RESULTS: In cultured Hep3B cells, pravastatin activated PPARα and PPARγ protein expression, induced stronger expression of PPARγ than that of PPARα, increased LXRα mRNA expression, activated ABCG5 and ABCG8 mRNA expression mediated by FXR as well as LXRα, enhanced FXR mRNA expression, and increased CYP7A1 mRNA expression mediated by the PPARγ and LXRα pathways, together or independently. CONCLUSION: Our data suggested that pravastatin prevents cholesterol gallstone diseases via the increase of FXR, LXRαand CYP7A1 in human hepatocytes. 展开更多
关键词 PRAVASTATIN PPARΓ liver x receptor α farnesoid x receptor gallstone disease
下载PDF
Coronary heart disease:Significance of liver X receptor α genomics 被引量:3
4
作者 Vivek Priy Dave Deepak Kaul 《World Journal of Cardiology》 CAS 2010年第6期140-149,共10页
Crosstalk between lipid peroxidation and inflammation is known to be a pathognomonic feature for the development of coronary heart disease(CHD).In this regard ligand activated liver X receptor(LXR)-α has emerged as a... Crosstalk between lipid peroxidation and inflammation is known to be a pathognomonic feature for the development of coronary heart disease(CHD).In this regard ligand activated liver X receptor(LXR)-α has emerged as a key molecular switch by its inherent ability to modulate an array of genes involved in these two fundamental cellular processes.In addition,LXR-α has also been found to play a role in hepatic lipogenesis and innate immunity.Although several lines of evidence in experimental model systems have established the atheroprotective nature of LXR-α,human subjects have been reported to possess a paradoxical situation in which increased blood cellular LXR-α gene expression is always accompanied by increased coronary occlusion.This apparent paradox was resolved recently by the finding that CHD patients possess a deregulated LXR-α transcriptome due to impaired ligand-receptor interaction.This blood cellular mutated LXR-α gene ex- pression correlated specifically with the extent of coro- nary occlusion and hence need is felt to devise new synthetic ligands that could restore the function of this mutated LXR-αprotein in order to modulate genes involved in reverse cholesterol transport and suppression of the inflammatory response leading to the effective treatment of CHD. 展开更多
关键词 CORONARY HEART disease liver x receptor LIPID METABOLISM Inflammation
下载PDF
Role of pregnane X-receptor in regulating bacterial translocation in chronic liver diseases 被引量:4
5
作者 Sundhar Mohandas Balasubramaniyan Vairappan 《World Journal of Hepatology》 CAS 2017年第32期1210-1226,共17页
Bacterial translocation(BT) has been impeccably implicated as a driving factor in the pathogenesis of a spectrum of chronic liver diseases(CLD). Scientific evidence accumulated over the last four decades has implied t... Bacterial translocation(BT) has been impeccably implicated as a driving factor in the pathogenesis of a spectrum of chronic liver diseases(CLD). Scientific evidence accumulated over the last four decades has implied that the disease pathologies in CLD and BT are connected as a loop in the gut-liver axis and exacerbate each other. Pregnane X receptor(PXR) is a ligandactivated transcription factor and nuclear receptor that is expressed ubiquitously along the gut-liver-axis. PXR has been intricately associated with the regulation of various mechanisms attributed in causing BT. The importance of PXR as the mechanistic linker molecule in the gutliver axis and its role in regulating bacterial interactions with the host in CLD has not been explored. Pub Med was used to perform an extensive literature search using the keywords PXR and bacterial translocation, PXR and chronic liver disease including cirrhosis. In an adequate expression state, PXR acts as a sensor for bile acid dysregulation and bacterial derived metabolites, and in response shapes the immune profile beneficial to the host. Activation of PXR could be therapeutic in CLD as it counter-regulates endotoxin mediated inflammation and maintains the integrity of intestinal epithelium. This review mainly focuses PXR function and its regulation in BT in the context of chronic liver diseases. 展开更多
关键词 Pregnane x receptor Bacterial translocation Chronic liver disease Intestinal permeability INFLAMMATION Tight junctions
下载PDF
逍遥丸对代谢相关脂肪性肝炎大鼠LXR-α/SREBP-1c通路的调节机制研究
6
作者 李梦琪 张馨月 +2 位作者 张玉伟 孟雅楠 苗宇船 《时珍国医国药》 CAS CSCD 北大核心 2024年第13期2919-2925,共7页
目的探讨逍遥丸对代谢相关脂肪性肝炎(MASH)大鼠的部分治疗机制,阐明中医“肝与大肠相通”理论对治疗MASH的指导意义。方法选取成年雄性SD大鼠24只,将其随机分为空白组(Control组)8只,模型0组(Model 0组)16只。其中Control组给予普通饲... 目的探讨逍遥丸对代谢相关脂肪性肝炎(MASH)大鼠的部分治疗机制,阐明中医“肝与大肠相通”理论对治疗MASH的指导意义。方法选取成年雄性SD大鼠24只,将其随机分为空白组(Control组)8只,模型0组(Model 0组)16只。其中Control组给予普通饲料喂养,Model 0组给予高脂饮食喂养,40%四氯化碳背部皮下注射,同时给予饥饱失常和夹尾刺激,4周后,将Model 0组随机分为模型组(Model组)和逍遥丸组(XYW组),每组各8只。XYW组大鼠给予逍遥丸灌胃,其他两组给予生理盐水灌胃。给药4周后,分别测定大鼠肝功能和肝脂肪指标含量;苏木精-伊红(HE)染色观察肝组织病理变化;阿利新蓝-过碘酸雪夫(AB-PAS)染色观察肠道屏障受损情况;ELISA试剂盒测定大鼠肝匀浆中炎症因子水平;qRT-PCR测定大鼠肝脏LXR-α、SREBP-1c、Nrf2及结肠Claudin1、ZO-1、SREBP-1c、Nrf2 mRNA的表达;Western blot检测大鼠肝脏LXR-α、SREBP-1c、Nrf2及结肠Claudin1、ZO-1、SREBP-1c、Nrf2的蛋白表达情况。结果与Control组比较,Model组大鼠血清ALT、AST以及肝匀浆T-CHO、TG、LDL-C、IL-8、IL-17、TNF-α水平升高(P<0.05),HDL-C、IL-10、TGF-β1水平降低(P<0.01);Model组大鼠肝组织LXR-α、SREBP-1c mRNA表达升高(P<0.001),Nrf2mRNA表达降低(P<0.01),结肠组织Claudin1、ZO-1、Nrf2 mRNA的表达降低(P<0.01),SREBP-1c的表达升高(P<0.01);Model组大鼠肝组织LXR-α、SREBP-1c蛋白水平升高(P<0.01),Nrf2降低(P<0.05),结肠组织中Claudin1、ZO-1、Nrf2蛋白水平降低(P<0.001),SREBP-1c升高(P<0.001)。结论逍遥丸对MASH大鼠具有一定的治疗作用,其治疗机制可能与减轻炎症、氧化应激反应,抑制脂肪酸堆积有关;保护肠黏膜屏障免受损害可以有效减轻肝脏的损伤,“肝与大肠相通”理论对于MASH治疗具有一定的指导意义。 展开更多
关键词 代谢相关脂肪性肝炎 逍遥丸 肝与大肠相通 x受体Α 固醇调节元件结合蛋白-1C 核因子E2相关因子
下载PDF
基于FXR/SHP/PEPCK和FXR/ApoCⅡ通路探讨茵陈五苓散对代谢相关脂肪性肝病大鼠糖脂代谢的作用
7
作者 石丹丹 艾碧琛 +2 位作者 李木兰 张毅 刘杰 《陕西中医》 2025年第2期153-158,共6页
目的:基于法尼醇X受体(FXR)/微小异源二聚体(SHP)/磷酸烯醇式丙酮酸羧激酶(PEPCK)和FXR/载脂蛋白CⅡ(ApoCⅡ)通路探讨茵陈五苓散对代谢相关脂肪性肝病(MAFLD)大鼠糖脂代谢的作用。方法:用高脂饮食建立MAFLD大鼠模型,将成模大鼠随机分为... 目的:基于法尼醇X受体(FXR)/微小异源二聚体(SHP)/磷酸烯醇式丙酮酸羧激酶(PEPCK)和FXR/载脂蛋白CⅡ(ApoCⅡ)通路探讨茵陈五苓散对代谢相关脂肪性肝病(MAFLD)大鼠糖脂代谢的作用。方法:用高脂饮食建立MAFLD大鼠模型,将成模大鼠随机分为模型组、茵陈五苓散高剂量组、茵陈五苓散低剂量组和辛伐他汀组,并选取同批次未进行造模处理的大鼠作为空白组。各组给予相应药物和0.9%氯化钠溶液干预4周。灌胃期间每周定时检测各组大鼠的体重和空腹血糖(FBG);生化法检测总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、谷丙氨酸氨基转移酶(ALT)及天冬氨酸氨基转移酶(AST)水平;ELISA法检测胰岛素(FINS)水平,并计算胰岛素抵抗指数(HOMA-IR);HE染色进行肝脏组织病理学观察;RT-qPCR法检测肝脏FXR、SHP、PEPCK、ApoCⅡmRNA水平。结果:与模型组比较,茵陈五苓散高剂量组、茵陈五苓散低剂量组和辛伐他汀组体重、肝重和肝指数明显降低(P<0.05);FBG、FINS和HOMA-IR水平明显降低(P<0.05);血清TG、TC、LDL-C、AST、ALT含量明显降低,HDL-C含量升高(P<0.01);肝组织结构均有不同程度的改善(P<0.01);FXR、SHP、ApoCⅡmRNA表达增加(P<0.01),PEPCK mRNA表达减少(P<0.01)。结论:茵陈五苓散能够改善MAFLD大鼠糖脂代谢紊乱和肝脏组织病理状态,其机制可能与调节FXR/SHP/PEPCK和FXR/ApoCⅡ通路有关。 展开更多
关键词 代谢相关脂肪性肝病 茵陈五苓散 糖代谢 脂代谢 法尼醇x受体 通路
下载PDF
Liver as a new target organ in Alzheimer's disease:insight from cholesterol metabolism and its role in amyloid-beta clearance
8
作者 Beibei Wu Yuqing Liu +4 位作者 Hongli Li Lemei Zhu Lingfeng Zeng Zhen Zhang Weijun Peng 《Neural Regeneration Research》 SCIE CAS 2025年第3期695-714,共20页
Alzheimer's disease,the primary cause of dementia,is characterized by neuropathologies,such as amyloid plaques,synaptic and neuronal degeneration,and neurofibrillary tangles.Although amyloid plaques are the primar... Alzheimer's disease,the primary cause of dementia,is characterized by neuropathologies,such as amyloid plaques,synaptic and neuronal degeneration,and neurofibrillary tangles.Although amyloid plaques are the primary characteristic of Alzheimer's disease in the central nervous system and peripheral organs,targeting amyloid-beta clearance in the central nervous system has shown limited clinical efficacy in Alzheimer's disease treatment.Metabolic abnormalities are commonly observed in patients with Alzheimer's disease.The liver is the primary peripheral organ involved in amyloid-beta metabolism,playing a crucial role in the pathophysiology of Alzheimer's disease.Notably,impaired cholesterol metabolism in the liver may exacerbate the development of Alzheimer's disease.In this review,we explore the underlying causes of Alzheimer's disease and elucidate the role of the liver in amyloid-beta clearance and cholesterol metabolism.Furthermore,we propose that restoring normal cholesterol metabolism in the liver could represent a promising therapeutic strategy for addressing Alzheimer's disease. 展开更多
关键词 ABCA1 Alzheimer's disease AMYLOID-BETA apolipoprotein E cholesterol metabolism liver liver x receptor low-density lipoprotein receptor-related protein 1 peripheral clearance tauroursodeoxycholic acid
下载PDF
Liver X receptors and epididymal epithelium physiology
9
作者 Fabrice Saez Eléore Chabory +4 位作者 Rémi Cadet Patrick Vernet Silvère Baron2 Jean-Marc A. Lobaccaro Joeol R. Drevet 《Asian Journal of Andrology》 SCIE CAS CSCD 2007年第4期574-582,共9页
Aim: To investigate the roles of liver X receptors (LXR) in the lipid composition and gene expression regulation in the murine caput epididymidis. LXR are nuclear receptors for oxysterols, molecules derived from ch... Aim: To investigate the roles of liver X receptors (LXR) in the lipid composition and gene expression regulation in the murine caput epididymidis. LXR are nuclear receptors for oxysterols, molecules derived from cholesterol metabolism that are present in mammals as two isoforms: LXRα, which is more specifically expressed in lipid-metabolising tissues, such as liver, adipose and steroidogenic tissues, and macrophages, whereas LXRβ is ubiquitous. Their importance in reproductive physiology has been sustained by the fact that male mice in which the function of both LXR has been disrupted have fertility disturbances starting at the age of 5 months, leading to complete sterility by the age of 9 months. These defects are associated with epididymal epithelial degeneration in caput segments one and two, and with a sperm midpiece fragility, leading to the presence of isolated sperm heads and flagella when luminal contents are recovered from the cauda epididymidis. Methods: The lipid composition of the caput epididymidis of wild-type and LXR-deficient mice was assessed using oil red O staining on tissue cryosections and lipid extraction followed by high performance liquid chromatography or gas chromatography. Gene expression was checked by quantitative real time polymerase chain reaction. Results: Using LXR-deficient mice, we showed an alteration of the lipid composition of the caput epididymidis as well as a significantly decreased expression of the genes encoding SREBPlc, SCD1 and SCD2, involved in fatty acid metabolism. Conclusion: Altogether, these results show that LXR are important regulators of epididymal function, and play a critical role in the lipid maturation processes occurring during sperm epididymal maturation. (Asian J Androl 2007 July; 9: 574-582) 展开更多
关键词 EPIDIDYMIS liver x receptors nuclear receptors LIPIDS CHOLESTEROL gene expression
下载PDF
基于肠FXR-FGF15通路探讨沙棘熊果酸对酒精性肝损伤小鼠的影响
10
作者 李楠 赵雪 +4 位作者 郭少龙 张文龙 戈娜 李智 林琰 《食品研究与开发》 2025年第2期9-15,共7页
该研究借助小鼠酒精性肝损伤模型,观察沙棘熊果酸补充对酒精性肝损伤(alcoholic liver disease,ALD)小鼠的改善效果,通过分析沙棘熊果酸对ALD小鼠肠法尼醇X受体(farnesoid X receptor,FXR)-成纤维细胞生长因子15(fibroblast growth fact... 该研究借助小鼠酒精性肝损伤模型,观察沙棘熊果酸补充对酒精性肝损伤(alcoholic liver disease,ALD)小鼠的改善效果,通过分析沙棘熊果酸对ALD小鼠肠法尼醇X受体(farnesoid X receptor,FXR)-成纤维细胞生长因子15(fibroblast growth factor 15,FGF15)通路的影响,探讨其可能的保护作用机制。结果表明,沙棘熊果酸能够改善ALD小鼠的肝脏、小肠组织炎症反应,降低ALD小鼠血清谷草转氨酶(aspartate transaminase,AST)、谷丙转氨酶(glutamicpyruvic transaminase,ALT)活性、总胆汁酸(total bile acids,TBA)、脂多糖(lipopolysaccharide,LPS)、D-乳酸(D-lactic acid,D-LA)含量,提高ALD小鼠胆盐水解酶(bile salt hydrolase,BSH)浓度。同时,沙棘熊果酸可提高ALD小鼠肠道FXR、FGF15、肝脏中成纤维细胞生长因子受体第4号(fibroblast growth factor receptor 4,FGFR4)蛋白表达量,降低肝脏中胆固醇7α-羟化酶(cholesterol 7α-hydroxylase,CYP7A1)蛋白表达。综上,沙棘熊果酸对酒精性肝损伤小鼠具有保护作用,其机制可能与调节肠FXR-FGF15通路有关。 展开更多
关键词 沙棘熊果酸 酒精性肝损伤 小肠 成纤维细胞生长因子15(FGF15) 法尼醇x受体(FxR) 胆汁酸
下载PDF
Role of liver X receptors alpha agonist on expressions of LPS-induced inflammatory response associated factor IRAK-4 and NF-kappaB in Kupffer cells
11
作者 Wang Ding Miao Chunmu Gong Jianping 《Journal of Medical Colleges of PLA(China)》 CAS 2008年第2期70-75,共6页
Objective: To explore the role of activated liver X receptor α (LXRα) on the expressions of interleukin-1 receptor associated kinase-4 (IRAK-4) and NF-kappaB (NF-κB) in the inflammatory response which induce... Objective: To explore the role of activated liver X receptor α (LXRα) on the expressions of interleukin-1 receptor associated kinase-4 (IRAK-4) and NF-kappaB (NF-κB) in the inflammatory response which induced by LPS in the Kupffer cells and to investigate the possible mechanisms of LXRα negative regulation of inflammatory response. Methods: The Kupffer cells were isolated from male Kunming mice by collagen perfusion in situ. And these cells were divided into 4 groups: normal control group, LPS treatment group, LXRct agonist T0901317 treatment group, LPS and T0901317 combined treatment group. The LPS treatment group were treated with a final concentration of 1 μg/ml LPS in RPMI 1640 and cultured for 6 h, the T0901317 treatment group were treated with a final concentration of 5 μg/ml in RPMI 1640 and cultured for 24 h, and the combined treatment group received pre-culture for 24 h with a final concentration of 1μg/ml T0901317 in RPMI 1640 and then cultured for 6 h with a final concentration of 5 μg/ml LPS in RPMI 1640. All groups were cultured for 30 h. The expression of LXRα, IRAK-4 and NF-κB at mRNA and protein levels were detected by real-time PCR and Western blotting, and the TNF-α and IL-1β levels were detected by ELISA. Results: The levels of LXRα mRNA and protein were highest in T0901317 group, and lowest in LPS group (P〈0.05). The level of IRAK4 and NF-κB mRNAs and proteins were evidently lower in the Combined-treated group than in LPS group (P〈0.05). And the level of TNF-α and IL-1 were observed highest in LPS group (P〈0.05), but no difference among the Control group, T0901317 group and Combined-treated group (P〉0.05). Conclusion: These date suggest that the LXR agonists can effectively up-regulate the expressions of LXRα mRNA and protein and inhibit the inflammatory response. This may be via down-regulating the expressions of IRAK4 and NF-κB at mRNA and protein levels. 展开更多
关键词 liver x receptors Kupffer cells Inflammation Interleukin-1 receptor associated kinase-4 NF-KAPPAB
下载PDF
Activation of Liver X Receptor Induces Macrophage Interleukin-5 Expression
12
作者 Yuan-Li Chen Ji-Hong Han Ya-Jun Duan 《中国动脉硬化杂志》 CAS CSCD 北大核心 2013年第9期I0074-I0074,共1页
关键词 LDL受体 巨噬细胞 白细胞介素 诱导 激活 氧化低密度脂蛋白 肝脏 动脉粥样硬化
下载PDF
疏肝和胃方调控PPAR-γ/RXR信号通路缓解胃食管反流病大鼠气道炎症的机制研究
13
作者 郑有浩 传芸 郑加梅 《实用临床医药杂志》 2025年第2期80-85,共6页
目的探讨疏肝和胃方通过调控过氧化物酶体增殖物激活受体γ/类视黄醇X受体(PPAR-γ/RXR)信号通路缓解胃食管反流病(GERD)大鼠气道炎症的机制。方法采用食管下端盐酸灌注法构建GERD合并气道炎症大鼠模型。将50只SD雄性大鼠随机分为对照... 目的探讨疏肝和胃方通过调控过氧化物酶体增殖物激活受体γ/类视黄醇X受体(PPAR-γ/RXR)信号通路缓解胃食管反流病(GERD)大鼠气道炎症的机制。方法采用食管下端盐酸灌注法构建GERD合并气道炎症大鼠模型。将50只SD雄性大鼠随机分为对照组、模型组、疏肝和胃方低剂量组(10.49 g/kg生药量)、疏肝和胃方高剂量组(20.98 g/kg生药量)和奥美拉唑组(3.67 mg/kg),每组10只,灌胃14 d。采用苏木精-伊红(HE)染色观察气管组织的病理学变化;采用RT-qPCR检测支气管肺泡灌洗液中炎症因子[白细胞介素(IL)-17、IL-33、诱导型一氧化氮合酶(iNOS)]以及抗炎因子[IL-10、克拉拉细胞蛋白16(CC16)、表面活性蛋白-D(SP-D)]的mRNA表达水平;采用免疫印迹法检测PPAR-γ、RXR-α、核因子-κB(NF-κB)、活化蛋白-1(AP-1)的蛋白相对表达量。结果HE染色结果显示,模型组可见大量炎症细胞浸润,疏肝和胃方低剂量组、高剂量组和奥美拉唑组炎症细胞浸润明显减少。与对照组比较,模型组支气管肺泡灌洗液中IL-17、IL-33、iNOS的mRNA表达水平升高,IL-10、CC16、SP-D的mRNA表达水平降低,PPAR-γ、RXR-α的蛋白相对表达量升高,NF-κB、AP-1的蛋白相对表达量降低,差异均有统计学意义(P<0.05)。与模型组比较,疏肝和胃方高剂量组和奥美拉唑组上述指标均有改善,差异有统计学意义(P<0.05)。结论疏肝和胃方可以有效缓解GERD大鼠气道炎症,其作用机制可能与激活PPARγ/RXR信号通路有关。 展开更多
关键词 疏肝和胃方 胃食管反流病 过氧化物酶体增殖物激活受体 类视黄醇x受体 信号通路
下载PDF
消痰化瘀中药对NAFLD大鼠LXRα mRNA和ABCA1表达的影响 被引量:4
14
作者 张一昕 邓国兴 +4 位作者 吴中秋 于文涛 徐晶 韩雪 潘思彤 《河北中医药学报》 2015年第2期1-3,7,共4页
目的:观察消痰化瘀中药对非酒精性脂肪肝(NAFLD)大鼠脂质代谢和肝脏LXRα和ABCA1mRNA表达的影响,探讨其作用机理。方法:随机将SD雄性大鼠分正常对照组、模型对照组、东宝肝泰对照组以及消痰化瘀中药高、中、低剂量组,一边造模一边灌胃... 目的:观察消痰化瘀中药对非酒精性脂肪肝(NAFLD)大鼠脂质代谢和肝脏LXRα和ABCA1mRNA表达的影响,探讨其作用机理。方法:随机将SD雄性大鼠分正常对照组、模型对照组、东宝肝泰对照组以及消痰化瘀中药高、中、低剂量组,一边造模一边灌胃给予相应药物。用药8周后,检测各组大鼠血清TC、TG、HDL、LDL、FFA和肝组织中TC、TG的含量改变,并观察肝组织LXRαmRNA和小肠ABCA1表达变化以及肝组织形态学的变化。结果:消瘀化痰中药能降低模型大鼠TC、TG、FFA、ALT、AST的含量或活性,促使LXRαmRNA和ABCA1的表达上调,改善肝组织的病变程度。结论:调控LXRα/ABCA1通路相关基因,促进肝脏脂质代谢,可能是消痰化瘀中药对NAFLD的治疗作用靶点之一。 展开更多
关键词 消瘀化痰中药 非酒精性脂肪肝 x受体 ATP结合盒转运蛋白A1
下载PDF
秦川牛LXRα基因第二外显子多态性及其与部分胴体、肉用性状关联性研究 被引量:12
15
作者 黄磊 昝林森 +1 位作者 王洪宝 刘洪瑜 《畜牧兽医学报》 CAS CSCD 北大核心 2010年第5期531-535,共5页
旨在分析秦川牛肝X受体基因(LXRα)第二外显子的遗传变异与部分酮体、肉用性能指标的相关性。随机选择相同饲养条件下的497头18~20月龄秦川牛阉牛,采用PCR-SSCP技术进行了LXRα基因部分区段遗传变异检测,运用SPSS程序中的GLM模型分析... 旨在分析秦川牛肝X受体基因(LXRα)第二外显子的遗传变异与部分酮体、肉用性能指标的相关性。随机选择相同饲养条件下的497头18~20月龄秦川牛阉牛,采用PCR-SSCP技术进行了LXRα基因部分区段遗传变异检测,运用SPSS程序中的GLM模型分析所检测到的遗传变异与秦川牛部分肉用性能指标的关联性。结果,找到了LXRα基因DNA序列中的一个突变位点T1530C(NC_007313)。对该遗传变异结果进行分型并与114头秦川牛的肉用性状进行关联分析,结果表明,该位点的多态性与胴体长、大理石花纹评分和背膘厚之间存在显著相关(P<0.05);BB和AB基因型个体胴体长显著高于AA基因型个体(P<0.05),BB基因型个体大理石等级和背膘厚显著高于AA基因型个体(P<0.05),与AB基因型个体差异不显著(P>0.05)。试验结果表明该SNP位点的BB基因型为优势基因型,与胴体长、背膘厚、大理石花纹等肉用性状有相关性,提示LXRα基因能够作为分子标记辅助选择的候选基因。 展开更多
关键词 秦川牛 x受体基因(lxrα) PCR-SSCP 肉用性状
下载PDF
疏肝健脾方药对非酒精性脂肪性肝病大鼠肝组织LXRα mRNA及蛋白表达的影响 被引量:9
16
作者 杨钦河 王文晶 +9 位作者 冯高飞 何秀敏 张玉佩 纪桂元 胡四平 王彦平 陈同炎 刘海涛 闫海震 黄进 《中国老年学杂志》 CAS CSCD 北大核心 2011年第22期4371-4375,共5页
目的探讨疏肝健脾方药对非酒精性脂肪性肝病(NAFLD)大鼠肝组织LXRαmRNA及蛋白表达的影响。方法选用SD大鼠55只,随机分为正常组、模型组、疏肝组(灌服3.2 g.kg-1·d-1剂量的柴胡疏肝散)、健脾组(灌服10.0 g.kg-1·d-1剂量的参... 目的探讨疏肝健脾方药对非酒精性脂肪性肝病(NAFLD)大鼠肝组织LXRαmRNA及蛋白表达的影响。方法选用SD大鼠55只,随机分为正常组、模型组、疏肝组(灌服3.2 g.kg-1·d-1剂量的柴胡疏肝散)、健脾组(灌服10.0 g.kg-1·d-1剂量的参苓白术散)、综合组(灌服11.9 g.kg-1·d-1剂量的柴胡疏肝散和参苓白术散合方),模型组15只,其余各组10只。采用灌饲高脂肪乳剂(10 ml/kg)的方法复制大鼠NAFLD实验动物模型,给药8 w后处死动物,腹主动脉采血,用全自动生化分析仪检测血脂及肝功;常规HE染色观察肝组织病理变化;RT-PCR方法检测肝组织LXRαmRNA的表达;免疫组织化学方法检测肝组织LXRα蛋白的表达。结果与正常组相比,模型组大鼠肝细胞脂肪变性明显,血脂及肝功均有不同程度的升高(P<0.05,P<0.01),大鼠肝组织LXRαmRNA及蛋白表达明显升高(P<0.01);各给药组血脂及肝功和肝组织LXRαmR-NA及蛋白的表达均较模型组显著降低(P<0.05,P<0.01),其中以健脾组下降最为明显。结论疏肝健脾方药对高脂饮食诱导的大鼠NAFLD有较好的治疗作用,其机制可能与其下调肝脏LXRα的表达有关。 展开更多
关键词 非酒精性脂肪性肝病 疏肝健脾方药 x受体α基因 大鼠
下载PDF
两种LXR激动剂对ApoE基因敲除小鼠动脉粥样硬化影响的对照研究 被引量:10
17
作者 颜伟 胡厚源 +2 位作者 周林 周向东 何国祥 《第三军医大学学报》 CAS CSCD 北大核心 2005年第5期381-384,共4页
目的 研究我校自行研制的LXR激动剂 (MHEC)和进口LXR激动剂 (T- 0 90 13 17)在抑制动脉粥样硬化病变形成方面的作用及主要机制。方法 以高脂饲养ApoE基因敲除 (ApoE / )小鼠为动脉粥样硬化模型 ,分为无药对照组、MHEC干预组和T -0 90... 目的 研究我校自行研制的LXR激动剂 (MHEC)和进口LXR激动剂 (T- 0 90 13 17)在抑制动脉粥样硬化病变形成方面的作用及主要机制。方法 以高脂饲养ApoE基因敲除 (ApoE / )小鼠为动脉粥样硬化模型 ,分为无药对照组、MHEC干预组和T -0 90 13 17干预组 ( 10mg·kg-1·d-1) ,每组 6只 ,灌胃 6周。检测血脂、分析主动脉壁中动脉粥样硬化病变的面积、用免疫组化SP法检测主动脉壁中ABCA1蛋白的表达。结果 T- 0 90 13 17组血浆总胆固醇 (TC)、甘油三酯 (TG)和高密度脂蛋白胆固醇 (HDL C)均显著高于对照组 (P <0 . 0 5 ,P <0 . 0 1) ,MHEC组仅HDL C显著高于对照组 (P <0. 0 1) ;药物干预组的动脉粥样硬化病变面积均显著降低 (P <0. 0 1) ,同时动脉壁中ABCA1的表达显著增强 (P <0 . 0 1)。结论 MHEC与T -0 90 13 17相比 ,有更好的血脂改善效果 ,二者均能显著抑制高脂饲养ApoE基因敲除小鼠动脉粥样硬化病变的形成。这可能与它们能促进动脉壁中ABCA1蛋白的表达 。 展开更多
关键词 肝孤儿受体 动脉粥样硬化 APOE基因敲除小鼠 T-0901317 三磷酸腺苷结合盒转运体A1
下载PDF
冠心康对ApoE^(-/-)动脉粥样硬化小鼠PPARγ-LXRα-ABCA1信号通路的影响 被引量:23
18
作者 毛美娇 胡俊萍 +2 位作者 王从 章怡祎 刘萍 《中西医结合学报》 CAS 2012年第7期814-820,共7页
目的:观察中药复方冠心康对载脂蛋白E(apolipoprotein E,ApoE)基因敲除(ApoE-/-)动脉粥样硬化(atherosclerosis,AS)小鼠三磷酸腺苷结合盒转运体A1(ATP-binding cassette transporterA1,ABCA1)通路的影响。方法:70只ApoE-/-小鼠用高脂饲... 目的:观察中药复方冠心康对载脂蛋白E(apolipoprotein E,ApoE)基因敲除(ApoE-/-)动脉粥样硬化(atherosclerosis,AS)小鼠三磷酸腺苷结合盒转运体A1(ATP-binding cassette transporterA1,ABCA1)通路的影响。方法:70只ApoE-/-小鼠用高脂饲料喂养建立小鼠AS模型。14只C57BL/6J小鼠为正常对照组,给予普通饲料。70只ApoE-/-小鼠造模成功后随机分为5组,即模型组、高剂量冠心康组(生药浓度为3.456g/mL)、中剂量冠心康组(1.728g/mL)、低剂量冠心康组(0.864g/mL)和西药辛伐他汀组[3mg/(kg·d)]。每只小鼠灌胃0.5mL,每天1次。连续灌胃8周后取材,分离肝脏及主动脉。运用蛋白质印迹法检测各组小鼠过氧化物酶体增殖物激活型受体γ(peroxisome proliferator-activated receptorγ,PPARγ)、肝X受体α(liver X receptor α,LXRα)和ABCA1蛋白的表达,实时荧光定量聚合酶链反应法检测各组小鼠主动脉、肝脏PPARγ、LXRα和ABCA1mRNA的表达。结果:与C57BL/6J小鼠比较,ApoE-/-小鼠的主动脉、肝脏的PPARγ、LXRα、ABCA1mRNA的表达明显增高;与模型组小鼠比较,高、中剂量冠心康与辛伐他汀在不同程度上下调了主动脉、肝脏的PPARγ、LXRα、ABCA1mRNA的表达(P<0.05),而以高剂量冠心康的作用最为突出。低剂量组无明显改变(P>0.05)。与C57BL/6J小鼠比较,ApoE-/-小鼠的主动脉、肝脏的PPARγ、LXRα、ABCA1蛋白的表达明显增高;与模型组小鼠比较,各用药组主动脉、肝脏的PPARγ、LXRα、ABCA1蛋白的表达量下降(P<0.05),而以冠心康高剂量组作用最为突出。结论:PPARγ-LXRα-ABCA1通路在ApoE-/-小鼠脂质代谢紊乱、炎症反应方面扮演重要角色。复方冠心康能改善ApoE-/-小鼠动脉粥样硬化过程中的脂质代谢紊乱,抑制炎症反应的进展,可能与调控ApoE-/-小鼠的主动脉、肝脏PPARγ、LXRα、ABCA1 mRNA及蛋白的表达有关。 展开更多
关键词 中草药 动脉粥样硬化 载脂蛋白E 三磷酸腺苷结合盒转运体A1 过氧化物酶体增殖物激活型受体Γ x受体Α 小鼠
下载PDF
草鱼LXRα基因的克隆及表达研究 被引量:4
19
作者 李超 刘品 +2 位作者 曹艳姿 吉红 林亚秋 《西北农林科技大学学报(自然科学版)》 CSCD 北大核心 2014年第6期1-9,共9页
【目的】克隆草鱼肝X受体α亚型(Liver X Receptor α,LXRα)cDNA序列,分析其在草鱼不同组织中的表达情况及n-3 HUFA对草鱼肝胰脏LXRα基因表达的影响。【方法】以草鱼肝胰脏组织为材料,采用RT-PCR技术对其LXRα基因cDNA进行克隆分... 【目的】克隆草鱼肝X受体α亚型(Liver X Receptor α,LXRα)cDNA序列,分析其在草鱼不同组织中的表达情况及n-3 HUFA对草鱼肝胰脏LXRα基因表达的影响。【方法】以草鱼肝胰脏组织为材料,采用RT-PCR技术对其LXRα基因cDNA进行克隆分析,运用生物信息学的方法分析该基因序列同源性。检测LXRα基因在草鱼10种组织中的表达情况。以含0.52% n-3 HUFA的饲料饲喂草鱼95 d后,用实时定量PCR法检测n-3 HUFA对肝胰脏LXRα表达的影响。【结果】克隆得到了草鱼LXRα cDNA序列(GenBank注册号为:FJ965309),其ORF序列长度为1 230 bp,编码409个氨基酸,预测该蛋白分子式为C2083H3343N581O611S30,分子质量为47 263.7 u,等电点pI为7.91,半衰期为30 h。该蛋白质具有哺乳动物的LXRS特征:包括DNA结合位点(DBD)、p-box,配体结合域 (LBD)、激活功能-2(AF-2)区域、D-box、D区域(D region) 和属于2个锌指结构的8个半胱氨酸;与其他物种LXRα的同源性为70.7%~100%,其中与鲤鱼和斑马鱼的同源性分别达100%和94.6%。LXRα基因在草鱼肝胰脏、肌肉、心脏、鳃、精巢、肾脏、脑、脾脏、肠、腹腔脂肪等10种组织中均有表达,其中在精巢中表达水平最高(P<0.05),在肌肉中表达水平最低 (P<0.05);饲喂n-3 HUFA可显著抑制草鱼肝胰脏LXRα基因的表达水平(P<0.01)。【结论】克隆获得了草鱼LXRα基因cDNA序列,该基因在多种组织中均可表达,其编码的氨基酸序列与其他物种相似性较高,在动物进化中比较保守;n-3 HUFA可通过影响草鱼肝胰脏LXRα基因的表达,调控草鱼的脂质代谢。 展开更多
关键词 草鱼 x受体α亚型 n-3 高不饱和脂肪酸
下载PDF
三七总皂甙对脂肪变性L02肝细胞TG含量及LXRα mRNA表达的影响 被引量:5
20
作者 程少冰 杨钦河 +4 位作者 张玉佩 杨环文 谢芳 薛川松 欧健 《中国病理生理杂志》 CAS CSCD 北大核心 2010年第6期1151-1155,共5页
目的:观察三七总皂甙(PNS)对脂肪变性L02肝细胞内甘油三酯(TG)含量及肝X受体α(LXRα)mRNA表达的影响,探讨其对脂肪变性肝细胞的降脂作用及机制。方法:采用50%小牛血清诱导L02肝细胞48 h建立肝细胞脂肪变性模型,采用MTT法测定PNS作用于... 目的:观察三七总皂甙(PNS)对脂肪变性L02肝细胞内甘油三酯(TG)含量及肝X受体α(LXRα)mRNA表达的影响,探讨其对脂肪变性肝细胞的降脂作用及机制。方法:采用50%小牛血清诱导L02肝细胞48 h建立肝细胞脂肪变性模型,采用MTT法测定PNS作用于脂肪变性肝细胞的适宜浓度,随后将其分为5组,模型组、自然恢复组、PNS低剂量组(10 mg.L-1)、PNS高剂量组(50 mg.L-1),并设正常组,除模型组继续予含50%小牛血清的RPMI-1640培养基培养外,余组均改予含10%小牛血清培养。药物作用24 h后,油红O染色观察肝细胞内脂滴变化,全自动生化仪检测肝细胞内TG含量,运用RT-PCR法检测肝细胞内LXRα mRNA的表达。结果:与正常组比较,油红O染色示模型组肝细胞内橘红色脂滴明显增加,并出现脂滴融合现象,模型组TG含量明显升高(P<0.01)。PNS治疗24 h后,PNS各治疗组与自然恢复组比较,肝细胞内TG含量均明显减少(P<0.05),以低剂量组下降更为显著(P<0.01);油红O染色显示,PNS低剂量组肝细胞内脂滴数减少最为明显。与正常组比较,模型组肝细胞LXRαmRNA的表达明显上调(P<0.01);与自然恢复组比较,PNS各治疗组肝细胞LXRα mRNA的表达量均有下降,以低剂量组下降显著(P<0.05)。结论:PNS能显著降低脂肪变性肝细胞内TG含量,减轻肝细胞脂肪变性。LXRα mRNA的高表达与肝细胞脂肪蓄积密切相关,PNS可能是通过下调LXRαmRNA的表达来改善肝细胞的脂肪变性。 展开更多
关键词 三七总皂甙 甘油三酯类 x受体Α 脂肪变性 L02细胞 肝疾病 非酒精性脂肪性
下载PDF
上一页 1 2 24 下一页 到第
使用帮助 返回顶部